This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • GA In NEwly Diagnosed Diffuse Large B Cell Lymphom...
Clinical trial

GA In NEwly Diagnosed Diffuse Large B Cell Lymphoma (GAINED)

Read time: 1 mins
Last updated:1st Sep 2012

This study is designed to investigate the interest of a new monoclonal antibody (GA101) versus rituximab and the interest of PET to identify early responders. Patients will receive either rituximab (standard treatment), either GA101 (study treatment), according to the randomization arm. The monoclonal antibody will be associated to a chemotherapy: CHOP or ACVBP according to site's choice.A PET scan will be done before inclusion, after 2 chemotherapy cycles, and after 4 chemotherapy cycles, to identify early patients responders, for who consolidation with ASCT is not required.

Category Value
Study start date 2012-09-01

View full details